Advisory board responsibilities

I am fortunate in having been able to enlist the help and guidance of an international board of editorial advisors who have provided great assistance by suggesting chapter topics and suitable authors for articles both here and in future volumes. While I am grateful for the assistance of this editorial advisory board, it is the editor and the authors who are solely responsible for any shortcomings of Topics in Stereochemistry. 

Advisory mechanisms the creation of a strategic advisory board to advise the VAE and of a Vaccine Acquisition Review Council and a Defense Medical Requirements Coimcil to advise the PEO, and a meeting between responsible DoD officials and the CEOs or COOs of major vaccine manufacturers to explain DoD s needs and to better understand the pharmaceutical industry s view of vaccine development... 

The response to this series will hopefully remain international. Contributions will continue to be solicited by the editor, who will be assisted by a newly appointed advisory board. However, suggestions for future articles and for more general comments regarding the series will be welcome at any time. 

The Issues discussed above were referred to the Science Advisory Board of the EPA Environmental Health Advisory Committee. The Agency has received a draft response from the Science Advisory Board In which changes In the procedures used to set tolerances are recommended. The Agency Is In the process of Implementing appropriate changes. 

The efforts to develop a harmonized system concerning direct safety, efficacy, and quality go back to 1965, when the first harmonized directive was issued [95]. Ten years later, the Committee for Proprietary Medicinal Products (CPMP) was established [96]. In 1989, the International Conference on Flarmonization (ICFI) was founded, and the EMEA began operation on January 1,1995 [97]. The EMEA serves as an advisory board, but is responsible for coordinating the approval, manufacturing, and inspection of medical products between the CPMP and member states regulatory bodies [98]. 

Editorial responsibility and authority for any manuscript authored by an editor and submitted to the editor s journal should be delegated to some other qualified person, such as another editor of that journal or a member of its Editorial Advisory Board. Editorial consideration of the manuscript in any way or form by the author-editor would constitute a conflict of interest, and is therefore improper. 

A few court decisions, however, have been more skeptical of the linear model. Eor example, the U.S. EPA s use of the linear, no-threshold model in its risk assessment for drinking water chlorinated byproducts was rejected by the court because it was contrary to evidence suggesting a nonlinear model that had been accepted by both the U.S. EPA and its Science Advisory Board (CCC 2000). On the other hand, the U.S. OSHA s departure from the linear, no-threshold model in its formaldehyde risk assessment was likewise rejected by the court (lU 1989). The court held that the U.S. OSHAhad improperly used the maximum likelihood estimate (MLE) rather than the upper confidence limit (UCL) to calculate risk, and the UCL but not the MLE model was consistent with a linear dose-response assumption. The court held that the U.S. OSHA had failed to justify its departure from its traditional linear, no-threshold dose-response assumption. 

Procedures/responslbllities a Responsible Care advisory board reviews H SE progress and makes recommendations, and procedures are compiled by the board of directors, the corporate management committtee and divisional management groups. 

EPA. 1991b. Science Advisory Board s review of the Office of Research and Development draft document Response to issues and data submissions on the carcinogenicity of tetrachloroethylene (perchloroethylene) (February 1991). U.S. Environmental Protection Agency. EPA-SAB-EHC-91-013. 

The FDA performs its duties with input from FDA Advisory Boards. These boards are made up of academic researchers whose responsibility is to provide independent advice and recommendations that are in the best interest of the general public. They must disclose any conflicts of interest related to subjects on which advice is being given. 

As a professor I have extensive interactions with industry, i serve on scientific advisory boards and i am aiso a consui-tant with several companies.The most important attribute is empathy for the agenda of company executives and the technical people who work in companies. That empathy allows one to appreciate their perspectives on research and the timeiines to which this research must be responsive."... 

It would be ideal if an individual or small group of biochemists could produce such an advanced treatise, and within the time to keep reasonably abreast of rapid advances, but this is at least difficult if not impossible. Instead, the Editors with the advice of the Advisory Board, have assembled what they consider the best possible sequence of chapters written by competent authors they must take the responsibility for inevitable gaps of subject matter and duplication which may result from this procedure. 

RALPH K. ILER is currentry a consultant and a member of the Advisory Board of the Journal of Colloid and Interface Science. He received his B.Sc. and Ph.D. degrees in chemical engineering from the University of Toronto, and worked for Canadian industries, Ltd. in Montreal and the Tire Division of U.S. Rubber Company at Detroit, Michigan. From 1937 to 1974, Dr. Her conducted research in various capacities for E.I. duPont de Nemours and Company. He is responsible for approximately 100 U.S. patents, and is the author of over 25 scientific publications and THE COLLOID CHEMISTRY OF SILICA AND SILICATES. 

---